Close Menu

NEW YORK (GenomeWeb) – Italian oncology genetics company Impact Lab Group announced yesterday that it has acquired Toma Advanced Biomedical Assays Services Lab for an undisclosed amount.

Toma — which is headquartered in Busto Arsizio, Italy — specializes in cytogenetics, molecular biology, and prenatal diagnostics, including research on reproductive diseases. Its merger with Milan-based Impact Lab will create the largest research and genetics laboratory in Italy, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.